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Abstract
Mucosa associated lymphoid tissue MALT lymphoma is a low grade malignancy that arises most
commonly from the gastric mucosa. Small intestinal involvement is very rare. The causative
relationship between Helicobacter pylori and the gastric MALT lymphoma is a well known issue, but
recently there are several data suggesting the role of hepatitis C virus (HCV) infection in the
pathogenesis of lymphoma including MALT lymphoma. Herein we present a rare case of duodenal
MALT lymphoma with multiple intra-abdominal thromboses together with HCV infection that was
confirmed by real-time polymerase chain reaction detecting HCV-RNA within the peripheral blood
mononuclear cells.
Background
Mucosa associated lymphoid tissue (MALT) lymphoma is
a neoplasm with low grade malignancy, arising from
MALT of various organs including gastrointestinal system,
salivary glands, lungs, thyroid glands, thymus, mammary
glands and lacrimal glands [1]. Among these sites, MALT
lymphoma arising from the gastric mucosa is most fre-
quently reported. Intestinal MALT lymphoma is a very
rare neoplasm and there is limited data about clinical and
pathological characteristics. The role of Helicobacter pylori
in the pathogenesis of gastric MALT lymphoma is a well
known issue. On the other hand, recently there are some
clues that hepatitis C virus (HCV) infection may be a pos-
sible contributing infectious factor in the pathogenesis of
MALT lymphoma [2,3].
Simultaneous portal, splenic and mesenteric vein throm-
bosis is a rare condition and may be associated with
malignancy, surgery, portal hypertension, hyperhomo-
cysteinemia, Behçet's disease, oral contraceptive use, fac-
tor V Leiden mutation, local inflammatory conditions and
hematological hypercoagulable states such as paroxysmal
nocturnal hemoglobinuria and myeloproliferative disor-
ders [4-6].
Herein we present a case with a history of periodic
abdominal pain bouts who admitted with new onset of
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and multiple intraabdominal venous thromboses.
Case Presentation
A 32 year old male presented with severe abdominal pain,
fatigue and nausea. He had a seven years history of peri-
odic abdominal pain attacks unrelated to meals and last-
ing for several days. He had once appendectomy and once
laparotomy for acute abdominal findings. Because he had
recurrent bouts of abdominal pain, colchicine treatment
was started considering the diagnosis of familial Mediter-
ranean fever (FMF). No objective improvement was
achieved on this treatment and the patient stopped taking
the drug because of the adverse effects such as diarrhea.
For the last three weeks, the abdominal pain persisted,
became very severe and worsened after meals with nausea
and vomiting. In physical examination, the patient was
pale and cachectic, abdominal examination revealed
guarding and diffuse abdominal tenderness to palpation.
There was ascites at level of umbilicus. The patient's past
history and family history were noncontributory. In the
initial radiological and biochemical assessment, there
were no sign of acute abdomen and thus laparotomy was
not indicated.
Results of initial laboratory analyses are shown in table 1.
Diagnostic paracentesis revealed ascites of portal type
(serum-ascites albumin gradient was 2.3 g/dL). The
cachexia and decreased levels of transferrin saturation,
cholesterol, triglyceride and albumin were assessed as a
sign of malabsorption and with these findings we consid-
ered a small intestinal disease.
In abdominal ultrasonography (USG), ascites and portal
and splenic vein thromboses were observed. Abdominal
computed tomography (CT) and CT angiography showed
increased wall thickness of intestinal loops, splenic, portal
and superior mesenteric vein thrombosis. Arterial pathol-
ogy was not detected (Figure 1). In small intestinal pas-
sage radiograph, 10 cm of descending part of the
duodenum, 7 cm of horizontal part of the duodenum and
4 cm of proximal part of the jejunum showed luminal
narrowing (Figure 2).
To determine the cause of multiple venous thrombosis in
the abdomen, thrombophilic parameters were investi-
gated: Anti-cardiolipin immunoglobulin (IG) G: 4.6
GPLU/mL; anti-cardiolipin IG M: 36.3 MPLU/mL; homo-
cystein (fasting level): 25.1 μmol/L (normal <12 μmol/L);
protein C: 94%; protein S: 83%; lupus anticoagulant was
negative; factor V Leiden and prothrombin gene muta-
tions were not detected. Immunophenotyping in the
peripheral blood revealed normal CD55 and CD59
expression and paroxysmal nocturnal hemoglobinuria
(PNH) was not considered. Vasculitis might be responsi-
ble for the thrombosis, so rheumatologic diseases were
investigated. For Behçet's disease, pathergy test, HLA-B51,
HLA-B52 were all negative. Anti-DNA, anti nuclear anti-
body, anti neutrophil cytoplasmic antibody, anti- Jo-1,
Table 1: Results of initial laboratory tests
Complete blood count Values References
WBC 7300/uL (4000-11,000)
Hb 7.4 g/dL (12-18)
Htc 23.5% (37-50)
MCV 64.0 fL (80-100)
Platelet 286000/uL (150,000-400,000)
Biochemistry
Creatinine 0.8 mg/dL (0.7-1.4)
Calcium 7.6 mg/dL (8.5-10.5)
Phosphrus 3.5 mg/dL (2.7-4.5)
ALP 398 U/L (30-135)
AST 24 U/L (5-42)
ALT 20 U/L (5-45)
LDH 474 U/L (240-480)
GGT 68 U/L (5-85)
Total bilirubin 0.60 mg/dL (0.2-1.0)
Indirect bilirubin 0.31 mg/dL (0.10-0.50)
Total cholesterol 88 mg/dL (130-200)
HDL 16 mg/dL (>40)
LDL 41 mg/dL (100-130)
Triglyceride 94 mg/dL (<30)
Total protein 4.6 g/dL (6.0-8.0)
Albumin 1.99 g/dL (3.2-5.5)
ESR 42 mm/h (0-20)
Hs-CRP 143.3 mg/L (0.0-5.0)
(White blood cells: WBC, Hemoglobin: Hb, Hematocrit:Htc, Mean 
corpuscular volume:MCV, Alkaline phosphatase:ALP, Aspartat 
aminotransferase:AST, Alanine aminotransferase:ALT, Lactate 
dehydrogenase:LDH, Gamma glutamyl transferase:GGT, High density 
lipoprotein: HDL, Low density lipoprotein:LDL, Erythrocyte 
sedimentation rate:ESR, high selective C reactive protein: hs-CRP)
Late phase contrast enhanced CT without oral contrast dem-onstrate  diffuse wall t ickening and narrowing in secon  p rt of th duodenum ( rrow)Figure 1
Late phase contrast enhanced CT without oral con-
trast demonstrates diffuse wall thickening and nar-
rowing in second part of the duodenum (arrow).Page 2 of 5
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rheumatoid factor were negative. FMF was considered
because of the recurrent bouts of abdominal pain, but
available FMF mutation assays were negative. Viral serol-
ogy was negative for hepatitis B virus (HBV) surface anti-
gen, anti HBV surface antibody and anti-HIV. Anti-HCV
(ELISA) was positive but HCV-RNA was negative (RT-PCR
method, Roche, COBAS Amplicor HCV monitor kit; lin-
ear measurement range: 600-700,000 UI/mL). To investi-
gate possible cryoglobulinemia associated with hepatitis
C infection; cryoglobulin and cryofibrinogen tests were
performed and found negative.
Because the patient had anti-HCV positivity but HCV-
RNA negativity with normal liver transaminases, to con-
firm the hepatitis C virus infection, HCV-RNA in the
plasma and peripheral blood mononuclear cells (PBMC)
was tested by RT-PCR method (analytic sensitivity for
serum is 20 IU/mL). HCV-RNA was detected in peripheral
blood mononuclear cells, so the patient was considered to
have hepatitis C virus infection. Liver biopsy revealed
non-specific reactive hepatitis and no sign of chronic viral
hepatitis, so antiviral treatment was not started.
Malabsorption associated with abdominal pain raised the
suspicion of intestinal T cell lymphoma following celiac
disease. Anti-gliadin immunoglobulin (Ig) A was 1.2 U/
mL and anti-gliadin Ig G was 20.4 U/mL. Anti-endomy-
sium Ig A was negative and serum Ig A level was 163 mg/
dL (normal: 68-425 mg/dL), so diagnosis of Celiac disease
was not considered.
In gastroduodenoscopy, duodenum was observed edema-
tous, fragile and granular; multiple small ulcerated lesions
were seen (Figure 3). Second part of the duodenum was so
narrowed that couldn't be passed through with the endo-
scope. Multiple duodenal and gastric biopsies were taken
during endoscopy. Pathological examination of the duo-
denal biopsy revealed atypical lymphoid infiltration with
centrocyte-like morphology; immunophenotypic investi-
gation was positive for CD 20 (+) and negative for CD 3
and CD 10 which were consistent with the diagnosis of
low grade MALT lymphoma of the duodenum (Figure 4,
5). Pathology of gastric biopsies was defined as non-
active, non-atrophic chronic gastritis. Helicobacter pylori
was negative in biopsy specimens. Colonoscopy was also
performed and was normal. In bone marrow biopsy, mild
hypercellularity was seen and infiltration was not
detected.
Diagnosis of MALT lymphoma of the small intestine was
considered and COP treatment protocol (cyclophospha-
mide 750 mg/m2 and 2 mg vincristine for once and 100
mg/day prednisolone for 5 days) was started. Because
Helicobacter pylori was negative in pathology specimens,
eradication therapy was not administrated. At follow up,
HCV RNA was still negative and liver function tests
remained stable. Because the patient had multiple venous
thromboses in abdomen, enoxaparine in treatment dose
followed by warfarin was started. After these treatments,
patient's complaints and findings of malabsorption were
dramatically improved. Control gastroduodenoscopy 4
months after treatment revealed regression of the lesions;
endoscopic biopsies were repeated in which no infiltra-
Upper gastrointestinal series shows multiple narrowing in second part of he duod num (arrows) and post-stenotic dil-atation in hird part of the duodenum (asterix)Figure 2
Upper gastrointestinal series shows multiple narrow-
ing in second part of the duodenum (arrows) and 
post-stenotic dilatation in third part of the duode-
num (asterix).
Endoscopic findings of the descending part of the duodenumFigure 3
Endoscopic findings of the descending part of the 
duodenum. Mucosa is observed edematous, fragile and 
granular; multiple small ulcerated lesions are also seen.Page 3 of 5
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ograph was normal.
Discussion
Primary gastrointestinal (GI) lymphoma accounts for
approximately 30% of all extranodal lymphomas [1,7].
However, primary GI lymphomas represent only 1-4% of
malignant tumors of the GI tract [8,9]. Sites of involve-
ment include the stomach, small intestine, ileo-cecal area
and large intestine. Lymphoma limited to the duodenum
is very rare, only a few cases are present in the literature.
The presenting symptoms of duodenal lymphoma are
insidious and non-specific and depend on the location of
the tumor, the degree of obstruction, and the rapidity of
growth. Our case presented with abdominal pain, nausea
and vomiting especially just after the meals probably
related to intestinal obstruction. He also had signs of mal-
absorption due to infiltration of the duodenum and jeju-
num. After successful treatment of lymphoma and
nutritional replacement therapy, all these findings sub-
sided.
Predisposing factors for lymphoma of the small intestine
include prior malabsorption syndromes (e.g. Celiac sprue
and dermatitis herpetiformis); inflammatory bowel dis-
ease (e.g. Crohn's disease), acquired immunodeficiency
states, Helicobacter pylori infection and possibly HCV infec-
tion. Infectious agents like Helicobacter pylori, Campylo-
bacter jejuni, Borrelia burgdorferi, Chlamydia psittaci and
HCV indirectly increases the probability of lymphoid
transformation by chronically stimulating the immune
system to maintain a protracted proliferative state [10].
HCV is both hepatotropic and lymphotropic. Association
between HCV infection and mixed cryoglobulinemia, a
benign lymphoproliferative disorder is well known but
the role of HCV in the pathogenesis of frank lymphoma is
not as certain, and is under ongoing discussion, but some
authors suggest that HCV may be considered, in addition
to Helicobacter pylori, as another potential infectious co-
factor in the multiple-stage pathogenesis of low-grade
lymphomas of MALT type [2].
Isolated anti-HCV positivity in individuals with negative
serum HCV-RNA may be related to past infection or false
positivity, but this has not yet been completely under-
stood. In our case, anti-HCV was positive but HCV-RNA
was negative and liver enzymes were normal. To confirm
the diagnosis of hepatitis C virus infection, HCV-RNA was
detected by RT-PCR within the PBMCs. Presence of HCV
within the lymphoid cells may have contributed to devel-
opment of intestinal MALT lymphoma, but to our knowl-
edge there is no published report investigating the
association of isolated anti-HCV positive hepatitis C virus
infection and lymphoma.
After the chemotherapy including corticosteroids, our
patient was followed by serial liver enzymes and HCV-
RNA tests, but signs of activation of HCV infection did not
occur; liver enzymes were always in normal range and
HCV-RNA was persistently negative.
One of the unique features of this case is the associated
multiple intraabdominal venous thrombosis, including
portal vein, splenic vein and superior mesenteric vein.
Patients with combination of these thromboses may
present with abdominal pain or findings of chronic portal
Endoscopic duodenal biopsy consistent with MALT lym-phomaFigure 4
Endoscopic duodenal biopsy consistent with MALT 
lymphoma. Neoplastic infiltration with centrocyte-like 
morphology that has partially effaced glandular structures in 
mucosa (HE, ×200)
Endoscopic duodenal biopsy, CD20 immunreactivity in infil-trative population ( nti-CD20 antibody clon  L-26, AEC chr mogene, ×100)Figure 5
Endoscopic duodenal biopsy, CD20 immunreactivity 
in infiltrative population (anti-CD20 antibody clone 
L-26, AEC chromogene, ×100).Page 4 of 5
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hypertension [5,6]. Our patient had a new onset abdomi-
nal pain different in character from the previous attacks
which may have been due to intestinal obstruction as well
as the thromboses. Known thrombophilic diseases were
investigated but no risk factors apart from mild hyperho-
mocysteinemia could be detected. Such combined throm-
boses are reported in patients with mild as well as severe
hyperhomocysteinemia but generally with other throm-
bophilic risk factors like essential thrombophilia and fac-
tor V Leiden mutation [4].
One of the most important mechanisms of hypercoagula-
bility in malignant diseases is the action of tissue factor,
which may be tumor cell-derived [11] or may originate
from the tumor-associated environment [12]. In our case
the venous thrombosis occurred in the proximity of the
tumor and this may be explained by the higher density of
the tumor cell-derived pro-thrombotic factors in the
neighboring great veins draining the malignant environ-
ment. To our knowledge there is no previous report of
portal, splenic or superior mesenteric vein thrombosis
associated with intestinal MALT lymphoma.
Conclusion
We have reported a rare case of MALT lymphoma of the
duodenum and jejunum together with multiple intraab-
dominal thromboses and HCV infection proven by detec-
tion of HCV-RNA in PBMCs. All patients with MALT
lymphoma should be screened for HCV infection. Iso-
lated anti-HCV positivity should be confirmed by detec-
tion of HCV-RNA in PBMCs to exclude false positivity,
because diagnosis of HCV infection is important in follow
up of patients who are given immunosuppresive chemo-
therapeutics for lymphoma. HCV infection may play a
role in the pathogenesis of MALT lymphoma beside Heli-
cobacter pylori and antiviral treatment for HCV may cause
regression of the MALT lymphoma and may be used for its
treatment similar to Helicobacter pylori eradication ther-
apy. Pathophysiological link between HCV infection and
MALT lymphoma and its impact on the treatment should
be further investigated.
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